Although many in vitro studies using cell lines have proven that mutations in the APC tumour suppressor gene occurs in most colorectal cancer and leads to the activation of β-catenin (Munemitsu et al, 1995; Morin et al, 1997), this probably is not always the case in vivo. This evidence concerns the gene APC and colorectal cancer.